4//SEC Filing
HCA Healthcare, Inc. 4
Accession 0001209191-17-035514
$HCACIK 0000860730operating
Filed
May 24, 8:00 PM ET
Accepted
May 25, 5:29 PM ET
Size
31.5 KB
Accession
0001209191-17-035514
Insider Transaction Report
Form 4
Davis Jana Joustra
SVP - Communications
Transactions
- Exercise/Conversion
Common Stock
2017-05-23$68.96/sh+5,500$379,280→ 138,767 total - Tax Payment
Common Stock
2017-05-23$81.93/sh−59,902$4,907,771→ 81,427 total - Exercise/Conversion
Stock Appreciation Right
2017-05-23−25,000→ 0 totalExercise: $37.18Exp: 2023-02-06→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Appreciation Right
2017-05-23−23,750→ 0 totalExercise: $37.18Exp: 2023-02-06→ Common Stock (23,750 underlying) - Exercise/Conversion
Stock Appreciation Right
2017-05-23−13,125→ 4,375 totalExercise: $47.97Exp: 2024-02-05→ Common Stock (13,125 underlying) - Exercise/Conversion
Stock Appreciation Right
2017-05-23−12,250→ 0 totalExercise: $47.97Exp: 2024-02-05→ Common Stock (12,250 underlying) - Exercise/Conversion
Stock Appreciation Right
2017-05-23−5,500→ 5,500 totalExercise: $68.96Exp: 2025-02-04→ Common Stock (5,500 underlying) - Exercise/Conversion
Stock Appreciation Right
2017-05-23−2,562→ 7,688 totalExercise: $69.58Exp: 2026-01-29→ Common Stock (2,562 underlying) - Exercise/Conversion
Common Stock
2017-05-23$47.97/sh+25,375$1,217,239→ 133,267 total - Exercise/Conversion
Common Stock
2017-05-23$69.58/sh+2,562$178,264→ 141,329 total - Sale
Common Stock
2017-05-23$82.35/sh−54,689$4,503,677→ 26,378 total - Exercise/Conversion
Common Stock
2017-05-23$37.18/sh+48,750$1,812,525→ 107,892 total
Holdings
- 29,397(indirect: By Trust)
Common Stock
Footnotes (7)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.48, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
- [F3]The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
- [F4]The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015.
- [F5]The stock appreciation rights vested at the end of fiscal years 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
- [F6]The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.
- [F7]The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.
Issuer
HCA Healthcare, Inc.
CIK 0000860730
Entity typeoperating
Related Parties
1- filerCIK 0000860730
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 5:29 PM ET
- Size
- 31.5 KB